- Prev Rank3
- LocationAnaheim, Calif.
- SectorHealth Care
- F1000 Rank-
- G500 Rank-
- Current Streak3
A remarkable transformation from obscure to blockbuster wonder drug: In the early 1990s, anti-inflammatory Acthar Gel sold for $50 per vial. Questor bought rights to the low-key drug in 2001 and began marketing it widely as a wonder drug used to treat kids with severe seizures.
In 2007, Acthar’s price increased from $1,650 to a whopping $23,000 for a 5-milliliter vial. The company explained that the astronomical price hike was needed to keep the drug available on the small, rare diseases market.
Today, a vial costs $28,000 and Questor has seen its annual revenues surge 97% in the past three years. In April, Questor was bought by Dublin-based pharma Mallinckrodt for $5.6 billion. —Vivian Giang
Revenue, Net Income
|Revenue Past Four Quarters|
|Net Income Past Four Quarters||327.9|
Growth Rates & Ranks
|EPS Growth Rank||13|
|EPS 3 yr Annual Growth Rate Pct||115|
|Revenue Growth Rank||3|
|Rev 3 yr Annual Growth Rate||97|
|Total Return 3 yr Annual Rate||59|
|Total Return Rank|
|Beat S&P 3 yr Annual Growth Rate?|
|P/E current fiscal year profits (est.)|